Hematologic Oncology
Innovative research focusing on chronic lymphocytic leukemia treatment combinations, evaluating the effectiveness of targeted therapies using ibrutinib and venetoclax. The trials aim to determine optimal treatment duration and progression-free survival outcomes.
- Treatment Response Assessment
- Progression-Free Survival
- Combination Therapy
Studies include monitoring of minimal residual disease and treatment optimization strategies.
Breast Cancer Research
Clinical investigations examining treatment approaches for elderly patients with HER2-negative breast cancer, particularly focusing on hormone receptor-positive cases. The research evaluates the effectiveness of combined chemotherapy and hormone therapy approaches.
- Genomic Profiling
- Elderly Patient Care
- Treatment Optimization
Research emphasizes personalized treatment strategies based on genomic grading.
Myeloid Disorders
Advanced studies on acute myeloid leukemia and high-risk myelodysplastic syndromes, investigating novel therapeutic combinations. The research focuses on evaluating the addition of midostaurin to decitabine treatment in specific patient populations.
- Treatment Response
- Novel Drug Combinations
- Patient Fitness Assessment
Trials specifically designed for patients with particular health status considerations.
